Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Destiny Pharma. (DEST)

Price 16.25p on 22-05-2024 at 16:30:02
Change -0.25p -1.52%
Buy 16.50p
Sell 16.00p
Buy / Sell DEST Shares
Last Trade: Sell 50,000.00 at 16.0525p
Day's Volume: 383,028
Last Close: 16.25p
Open: 16.50p
Day's Range 16.25p - 16.50p
52wk Range: 14.50p - 82.00p
Market Capitalisation: £15m
VWAP: 16.17468p
Shares in Issue: 95m

Recent Trades History Destiny Pharma. (DEST)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 50,000 16.0525p Ordinary
14:41:09 - 22-May-24
Unknown* 80,000 16.25p Ordinary
14:29:42 - 22-May-24
Unknown* -50,000 16.25p Ordinary
14:29:42 - 22-May-24
Unknown* 50,000 16.25p Ordinary
14:29:42 - 22-May-24
Sell* 1,074 16.1551p Ordinary
13:24:22 - 22-May-24
Sell* 4,790 16.1551p Ordinary
11:41:48 - 22-May-24
Sell* 24,089 16.00p Ordinary
10:08:25 - 22-May-24
Buy* 61,178 16.34p Ordinary
10:08:00 - 22-May-24
Sell* 5,000 16.005p Ordinary
08:42:19 - 22-May-24
Sell* 3,000 16.005p Ordinary
08:33:08 - 22-May-24

Share Price History for Destiny Pharma.

Time period:
Date Open High Low Close Volume

Share News for Destiny Pharma.

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

25th Apr 2024 20:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract

25th Apr 2024 10:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

UK earnings, trading statements calendar - next 7 days

18th Apr 2024 14:17

Read More

EARNINGS AND TRADING: STV raises holding in Two Cities Television

31st Jan 2024 18:28

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Destiny Pharma seeks to capitalise on XF-73 market potential in 2024

4th Jan 2024 14:07

(Alliance News) - Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered